GB842325A - Pharmaceutical compositions containing aminoguanidine derivatives - Google Patents
Pharmaceutical compositions containing aminoguanidine derivativesInfo
- Publication number
- GB842325A GB842325A GB2984056A GB2984056A GB842325A GB 842325 A GB842325 A GB 842325A GB 2984056 A GB2984056 A GB 2984056A GB 2984056 A GB2984056 A GB 2984056A GB 842325 A GB842325 A GB 842325A
- Authority
- GB
- United Kingdom
- Prior art keywords
- agents
- stands
- substituted
- sterile
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical compositions useful in the treatment of allergic and inflaminatory conditions e.g. asthma, hay fever, allergic eczemas and purpuras comprise as the active ingredient a guanidine compound of the formula:- <FORM:0842325/VI/1> wherein R1 stands for an aryl radical which may optionally be substituted, R2 stands for hydrogen or a hydrocarbon radical which may optionally be substituted and R3 stands for a hydrocarbon radical at a heterocyclic radical bath of which may be optionally substituted, provided that when R3 is heterocyclic R2 is hydrogen, and wherein R2 and R3 may be joined with the adjacent carbon atom to form a homo- or heterocyclic ring, or a salt thereof. Such salts may be mineral acid salts or organic acid salts e.g. acetates and salicylates. The compositions may take the form of oral preparations e.g. coated or uncoated tablets, aqueous and oily suspensions, dispersible granules, emulsions or hard or soft capsules; preparations for tropical application e.g. creams, ointments or pastes; or preparations suitable for injection e.g. sterile aqueous or oily suspensions, sterile powders for the preparation of injectable solutions and sterile dispersible powders for preparing injectable aqueous suspensions. The compositions contain the conventional adjuvants e.g. tablet excipients, dispersing agents, suspending agents, emulsifying agents, flavouring agents and preserving agents. Specifications 842,322, 842,323 and 842,324 are referred to.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2984056A GB842325A (en) | 1956-10-01 | 1956-10-01 | Pharmaceutical compositions containing aminoguanidine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2984056A GB842325A (en) | 1956-10-01 | 1956-10-01 | Pharmaceutical compositions containing aminoguanidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB842325A true GB842325A (en) | 1960-07-27 |
Family
ID=10298053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2984056A Expired GB842325A (en) | 1956-10-01 | 1956-10-01 | Pharmaceutical compositions containing aminoguanidine derivatives |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB842325A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2108867A1 (en) * | 1970-10-14 | 1972-05-26 | Ugine Kuhlmann | Cyclododecanylidene - amino-guanidine - as a hypoglycaemic agent |
WO1984003292A1 (en) * | 1983-02-25 | 1984-08-30 | Du Pont | Polyoxymethylene/polyurethane compositions containing ethylene bis-stearamide |
US5510353A (en) * | 1991-03-22 | 1996-04-23 | Sandoz Ltd. | Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain |
DE10149919A1 (en) * | 2001-10-10 | 2003-04-24 | Biosphings Ag | New carboxylic acid salts of guanidine derivatives useful as sphingomyelinase inhibitors for treating e.g. tumor, cardiovascular or viral diseases |
-
1956
- 1956-10-01 GB GB2984056A patent/GB842325A/en not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2108867A1 (en) * | 1970-10-14 | 1972-05-26 | Ugine Kuhlmann | Cyclododecanylidene - amino-guanidine - as a hypoglycaemic agent |
WO1984003292A1 (en) * | 1983-02-25 | 1984-08-30 | Du Pont | Polyoxymethylene/polyurethane compositions containing ethylene bis-stearamide |
US5510353A (en) * | 1991-03-22 | 1996-04-23 | Sandoz Ltd. | Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain |
DE10149919A1 (en) * | 2001-10-10 | 2003-04-24 | Biosphings Ag | New carboxylic acid salts of guanidine derivatives useful as sphingomyelinase inhibitors for treating e.g. tumor, cardiovascular or viral diseases |
US7078566B2 (en) | 2001-10-10 | 2006-07-18 | Biosphinks Aktiengesellschaft | Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES462065A1 (en) | Thiazolidine derivatives | |
ES345981A1 (en) | Pyridines and poultry feedstuffs and additives thereof containing pyridines | |
GB842325A (en) | Pharmaceutical compositions containing aminoguanidine derivatives | |
GB939901A (en) | Improvements in or relating to amino pyrazoles | |
US2581850A (en) | Adrenochrome compositions | |
GB997375A (en) | Isothiazole derivatives | |
ES8307224A1 (en) | Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them. | |
GB1262292A (en) | Novel thiazoline derivatives, the preparation thereof and compositions containing the same | |
JPS61207331A (en) | Heterocyclic disulfide | |
GB1091109A (en) | New derivative of phenylbutazone and its preparation | |
GB1073521A (en) | Indole derivatives | |
GB972672A (en) | Pharmaceutical preparations containing compounds of the androstane series | |
GB819681A (en) | Improvements in and relating to quaternary ammonium compounds and the preparation thereof | |
GB1505849A (en) | 9,10-dihydroanthracen-9,10-imine derivatives | |
GB964561A (en) | New sulphonamides and process for preparing them | |
ES342394A1 (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same | |
GB863342A (en) | Improvements in or relating to griseofulvin preparations | |
GB919269A (en) | Antiseptic compositions comprising quinaldine derivatives | |
GB1082943A (en) | Derivatives of 7-aminocephalosporanic acid | |
GB936919A (en) | Pharmaceutical compositions comprising homochlorcyclizine | |
GB1235409A (en) | Improvements in or relating to anticestode hydrazinoquinolines | |
GB962889A (en) | New salts of n-(5-nitrofurfurylidene)-1-aminohydantoin | |
ES342072A1 (en) | Biologically Active Propionamidines and their preparation | |
GB888923A (en) | New ethers and process for their manufacture | |
GB886520A (en) | Improvements relating to amphoteric biocidalimidazolidine and hexahydropyrimidine derivatives and their use |